Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie Pricing Pact And Cancer Trial Data Reframe Long Term Outlook

AbbVie (NYSE:ABBV) has agreed a three year deal with the Trump administration to cut US drug prices and invest $100b in US based R&D, manufacturing, and patient access. The company also reported positive topline Phase 3 results for its bispecific antibody epcoritamab in relapsed or refractory diffuse large B cell lymphoma, with improved progression free survival and response rates. AbbVie enters this news cycle with a current share price of $223.93 and a value score of 5 on Simply Wall St,...
NasdaqGS:GLDD
NasdaqGS:GLDDConstruction

A Look At Great Lakes Dredge & Dock (GLDD) Valuation After The East Rockaway Inlet Dredging Contract

The U.S. Army Corps of Engineers’ $14 million East Rockaway Inlet dredging and beach replenishment project, which uses a Great Lakes Dredge & Dock (GLDD) cutter-head dredge, has put fresh attention on the company’s contract pipeline and revenue visibility. See our latest analysis for Great Lakes Dredge & Dock. GLDD’s involvement in the East Rockaway project comes after a period of strong share price momentum, with a 30 day share price return of 13.94% and a 90 day share price return of...
NasdaqCM:OVLY
NasdaqCM:OVLYBanks

Oak Valley Bancorp (OVLY) Margin Easing Challenges Steady Compounder Narrative In FY 2025 Results

Oak Valley Bancorp FY 2025 earnings snapshot Oak Valley Bancorp (OVLY) has wrapped up FY 2025 with fourth quarter total revenue of about US$20.4 million and basic EPS of roughly US$0.77, setting the tone for how the full year’s numbers land for shareholders. The company has seen quarterly revenue move between US$19.3 million and US$21.2 million over the past six reported periods, while basic EPS has ranged from about US$0.64 to US$0.89, giving investors a clearer view of how the income line...
NasdaqGS:FSBC
NasdaqGS:FSBCBanks

Five Star Bancorp (FSBC) Net Interest Margin Beat Reinforces Bullish Profitability Narratives

Five Star Bancorp (FSBC) has put up another solid quarter for FY 2025, with Q3 revenue of US$38.8 million and EPS of US$0.77, underpinned by net income of US$16.3 million. The company has seen revenue move from US$29.0 million in Q3 FY 2024 to US$38.8 million in Q3 FY 2025, while EPS over that same stretch has gone from US$0.52 to US$0.77, setting up the latest results as part of a clear earnings ramp in a backdrop where margins are a key focus for investors. See our full analysis for Five...
NasdaqGS:HBCP
NasdaqGS:HBCPBanks

Home Bancorp (HBCP) Margin Strength And 22.6% Earnings Growth Challenge Cautious Narratives

Home Bancorp (HBCP) has wrapped up FY 2025 with fourth quarter revenue of US$37.7 million and basic EPS of US$1.48, backed by trailing twelve month revenue of US$148.7 million and EPS of US$5.93 that sit alongside 22.6% earnings growth over the last year. Over the past few quarters, the company has seen revenue range from US$33.9 million in Q3 2024 to US$38.1 million in Q3 2025. Quarterly EPS has moved from US$1.19 to as high as US$1.60, setting up a year where a 30.5% trailing net profit...
NEOE:BTQ
NEOE:BTQSoftware

Assessing BTQ Technologies (NEOE:BTQ) Valuation After New Quantum Compute In Memory Chip Partnership

Why BTQ’s new chip partnership matters for shareholders BTQ Technologies (NEOE:BTQ) has drawn fresh attention after announcing a collaboration with Taiwan’s Industrial Technology Research Institute to advance and validate its Quantum Compute In Memory chip for post quantum cryptographic hardware. See our latest analysis for BTQ Technologies. Even with this new chip collaboration in focus, BTQ Technologies’ share price has been under pressure recently. The 30 day share price return shows a...
NasdaqCM:LNKB
NasdaqCM:LNKBBanks

LINKBANCORP (LNKB) Net Margin Jumps To 31.1% Challenging Cautious Earnings Narratives

LINKBANCORP (LNKB) closed out FY 2025 with fourth quarter revenue of US$23.45 million and basic EPS of US$0.08, while trailing twelve month revenue came in at US$118.04 million and EPS at US$0.90, alongside very large year over year earnings growth and a higher net profit margin of 31.1% versus 6.5% a year earlier. Over the last few quarters the company has seen revenue move from US$28.01 million and EPS of US$0.20 in Q4 2024 to a range of US$23.45 million to US$38.86 million and EPS between...
NYSE:O
NYSE:ORetail REITs

Realty Income Broadens Growth With Mexico Entry And Fee-Based Platform

Realty Income (NYSE:O) has made its first investment in Mexican commercial real estate, entering the country through a new partnership and capital commitment. The company has also launched an asset management business focused on institutional investors, designed to generate recurring fee income. These moves come as Realty Income trades around $60.92, with the stock up 17.2% over the past year and 33.6% over the past five years. For a company known primarily for its net lease REIT model,...
NasdaqGS:CCBG
NasdaqGS:CCBGBanks

Capital City Bank Group (CCBG) Margin Strength Supports Bullish Narratives Despite Softer Quarterly EPS

Capital City Bank Group (CCBG) closed FY 2025 with fourth quarter total revenue of US$61.5 million and basic EPS of US$0.80, alongside net income of US$13.7 million. On a trailing twelve month basis, EPS stood at US$3.61 on revenue of US$248.7 million and net income of US$61.6 million. Over the past year, the company has seen trailing twelve month revenue move from US$230.9 million to US$248.7 million and EPS rise from US$3.12 to US$3.61, giving you a clear sense of the earnings power behind...
NYSE:IVZ
NYSE:IVZCapital Markets

Invesco (IVZ) Net Inflows And Profit Rebound Challenge Longstanding Bearish Earnings Narratives

Invesco (IVZ) has put up a cleaner set of numbers for FY 2025 so far, with Q3 revenue at US$1,640.4 million and EPS of US$0.67, alongside trailing 12 month revenue of US$6,278.1 million and EPS of US$1.47 that support the story of a business that has moved back into the black. Over the past few quarters, revenue has ranged from US$1,483.3 million in Q2 2024 to US$1,640.4 million in Q3 2025, while quarterly EPS has run from a loss of US$0.03 in Q2 2025 to a profit of US$0.67 in Q3 2025, giving...
TSX:ATZ
TSX:ATZSpecialty Retail

Do Aritzia’s (TSX:ATZ) Shareholder Sales Hint At A Shifting Long-Term Ownership Story?

Aritzia Inc. recently filed a final short form prospectus for a bought deal secondary offering, enabling selling shareholders to sell 1,537,000 subordinate voting shares at $130.20 per share, with an additional 230,550 shares available to underwriters through an over-allotment option. While these shares are being sold by existing investors rather than raising new capital for Aritzia, the move highlights shifting shareholder ownership alongside ongoing efforts to manage higher U.S...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Nebius Group (NBIS) Valuation Check As Rebrand And Major AI Contracts Reshape Growth Story

Nebius Group (NBIS) has just completed its rebrand from Yandex and returned to trading, with fresh attention on its AI infrastructure contracts with Microsoft and Meta Platforms and the investment risks tied to rapid expansion. See our latest analysis for Nebius Group. The rebrand and the AI capacity deals appear to be the main backdrop for Nebius Group’s volatile year, with a 1-year total shareholder return of 225.26% alongside a 90-day share price return decline of 21.77% and a latest close...
OTCPK:WCCB
OTCPK:WCCBBanks

West Coast Community Bancorp (OTCPK:WCCB) Non Performing Loan Spike Challenges Bullish Narratives

West Coast Community Bancorp (WCCB) has put up another solid set of numbers for FY 2025, with third quarter revenue at US$32.4 million and basic EPS of US$1.15, supported by trailing twelve month revenue of US$125.0 million and EPS of US$3.86. The company has seen revenue move from US$86.9 million and EPS of US$4.24 on a trailing basis in the second quarter of FY 2024 to US$125.0 million and EPS of US$3.86 by the third quarter of FY 2025. Over the same span, trailing net income shifted from...
TSX:TD
TSX:TDBanks

TD Bank Expands Capital Markets While Accelerating Buybacks And Debt Redemption

Toronto-Dominion Bank (TSX:TD) is expanding its debt and equity capital markets business by hiring six senior bankers from rival institutions. The bank has also announced a new multi billion dollar share repurchase program. TD plans to redeem CA$1.25b in subordinated notes as part of its latest capital actions. For investors watching Toronto-Dominion Bank, the combination of capital markets hiring and balance sheet moves comes on top of a long record of share price performance. TSX:TD last...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax AI Fraud And Verification Push Meets Undervalued Share Price Outlook

Equifax (NYSE:EFX) has launched Synthetic Identity Risk, an AI and machine learning based tool aimed at detecting and preventing synthetic identity fraud. A few days later, the company introduced Income Confirm, which combines The Work Number data with Equifax credit reports to support employment and income verification during lending. Equifax, trading at $208.03, is rolling out these products at a time when synthetic identity fraud and verification complexity are key concerns for lenders...
NasdaqGS:NBTB
NasdaqGS:NBTBBanks

NBT Bancorp (NBTB) Margin Strength And 20.3% Earnings Growth Reinforce Bullish Narratives

NBT Bancorp (NBTB) just wrapped up FY 2025 with fourth quarter revenue of US$181.4 million and basic EPS of US$1.06, capping a trailing twelve month run to US$664.8 million in revenue and EPS of US$3.34. Over the past few quarters, revenue has moved from US$146.3 million in Q4 2024 to US$181.4 million in Q4 2025, while quarterly EPS has ranged from US$0.45 in Q2 2025 to just over US$1.06 most recently. This gives investors a clear view of how the top and bottom lines have tracked through the...
TSE:4568
TSE:4568Pharmaceuticals

Is Daiichi Sankyo (TSE:4568) Turning ENHERTU’s China Approval Into a Durable Oncology Advantage?

Daiichi Sankyo recently gained approval in China for ENHERTU as the first HER2-directed antibody-drug conjugate for second-line treatment of HER2 positive metastatic gastric cancer, while also advancing its ADC pipeline and transitioning leadership at its Translational Research Center Europe. This approval taps into China’s large gastric cancer burden and underscores the central role of Daiichi Sankyo’s DXd ADC platform in its oncology franchise. We’ll now examine how ENHERTU’s new gastric...